Minivelle 0.0375 MG per 24HR Twice Weekly Transdermal Patch

RxCUI: 1356979
RxNorm name: Minivelle 0.0375 MG per 24HR Twice Weekly Transdermal Patch
Display name: Minivelle 0.0375 MG per 24HR Twice Weekly Transdermal Patch
Full name: Minivelle 0.0375 MG per 24HR Twice Weekly Transdermal Patch
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Minivelle	ESTRADIOL	Noven Therapeutics, LLC	6c5c47ab-28ee-11e1-bfc2-0800200c9a66	2026-07-31	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1356979

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
6c5c47ab-28ee-11e1-bfc2-0800200c9a66	Minivelle 0.0375 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00156 MG/HR Transdermal System [Minivelle] [SBD] · 84 HR Minivelle 0.00156 MG/HR Transdermal System [SY] · Minivelle 0.0375 MG per 24HR Twice Weekly Transdermal Patch [SY] · Minivelle 0.0375 MG/Day Twice Weekly Transdermal System [SY]	5	19	These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 1975	20240222